Dissemin is shutting down on January 1st, 2025

Published in

American Medical Association, JAMA Health Forum, 8(3), p. e222839, 2022

DOI: 10.1001/jamahealthforum.2022.2839

Links

Tools

Export citation

Search in Google Scholar

Federal and State Pharmacy Regulations and Dispensing Barriers to Buprenorphine Access at Retail Pharmacies in the US

Journal article published in 2022 by Dima M. Qato ORCID, Jonathan H. Watanabe, Kelly J. Clark
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

This Viewpoint describes federal and state pharmacy regulations that may create barriers to buprenorphine access at pharmacies and suggests policy changes to address those barriers.